EcoDrugPlus

Ribosomal Protein S29

Ensembl ID : ENSBSLG00000019361
Gene Symbol: RPS29
3 Cross references
212 Possible Orthologues:

Ribosomal Protein S3a

Ensembl ID : ENSBSLG00000004532
Gene Symbol: RPS3A
3 Cross references
336 Possible Orthologues:

Ribosomal Protein S5

Ensembl ID : ENSBSLG00000011291
Gene Symbol: RPS5
3 Cross references
257 Possible Orthologues:

Ribosomal Protein S7

Ensembl ID : ENSBSLG00000006365
Gene Symbol: RPS7
3 Cross references
370 Possible Orthologues:

Ribosomal Protein S8

Ensembl ID : ENSBSLG00000023337
Gene Symbol: RPS8
3 Cross references
327 Possible Orthologues:

Ribosomal Protein S9

Ensembl ID : ENSBSLG00000017699
Gene Symbol: RPS9
3 Cross references
237 Possible Orthologues:

Ribosomal Protein Lateral Stalk Subunit P1

Ensembl ID : ENSBSLG00000010024
Gene Symbol: RPLP1
3 Cross references
386 Possible Orthologues:

Selectin P

Ensembl ID : ENSBSLG00000002361
Gene Symbol: SELP
1 Cross references
173 Possible Orthologues:

Serine/threonine-Protein Kinase A-Raf-Like

Ensembl ID : ENSBSLG00000019495
Gene Symbol: LOC114845646
3 Cross references
191 Possible Orthologues:

Serine/threonine-Protein Kinase Chk2-Like

Ensembl ID : ENSBSLG00000004495
Gene Symbol: LOC114861437
3 Cross references
206 Possible Orthologues:

Serine/threonine-Protein Kinase Pim-1-Like

Ensembl ID : ENSBSLG00000018310
Gene Symbol: LOC114859131
3 Cross references
250 Possible Orthologues:

Serpin Family C Member 1

Ensembl ID : ENSBSLG00000012639
Gene Symbol: SERPINC1
3 Cross references
201 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).